- Release Date: 12/09/14 14:00
- Summary: GENERAL: CVT: Edison Investment Research Limited releases Comvita Report
- Price Sensitive: No
- Download Document 2.05KB
CVT 12/09/2014 14:00 GENERAL REL: 1400 HRS Comvita Limited GENERAL: CVT: Edison Investment Research Limited releases Comvita Report Comvita has commissioned Edison Investment Research Limited to provide an independent report on the company. Edison has released a corporate outlook report that has been written using publicly available information. Please note that the conclusions and opinions in the report are those of Edison Investment Research Limited. Edison Investment Research Limited will provide ongoing regular analysis which we will make available to shareholders. Ends For further information: Brett Hewlett, Comvita CEO, 021 740 160 Julie Chadwick, Comvita Communications Manager, 021 510 693 Background information About Comvita (www.comvita.com) Comvita (NZX:CVT) is a global natural health company committed to the development of innovative products, backed by ongoing investment in scientific research. We are the world leaders in Manuka (leptospermum) honey and fresh-picked Olive Leaf Extract, which are at the core of the Comvita product range. We have approximately 50% of honey supply under direct ownership or control, with the balance of supply from long term contractual and partnership arrangements. Comvita pioneered the development and use of medical grade Manuka honey and was the first to receive FDA approval (2007). We partner with US wound care company Derma Sciences Inc., (NASDAQ:DSCI), the global licensee for Medihoney specialist wound care products, which are used in hospitals and medical centres around the world. Comvita's Olive Leaf Extract is grown, harvested, extracted and bottled at the world's largest specialised olive leaf grove, with over one million olive trees. Comvita sells into more than 18 countries through a network of our own branded retail locations, online (nine country specific e-commerce websites) and third-party outlets. We have over 450 staff located in New Zealand, Australia, Hong Kong, Japan, Taiwan, South Korea, the United Kingdom and the USA. End CA:00255182 For:CVT Type:GENERAL Time:2014-09-12 14:00:35
- Forums
- NZX - By Stock
- Ann: GENERAL: CVT: Edison Investment Research Limited releases Comvita Report
Ann: GENERAL: CVT: Edison Investment Research Limited releases...
Featured News
Add CVT (NZSX) to my watchlist